These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 28951820)
21. Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes. Wen X; Yang Y J Mol Endocrinol; 2017 Feb; 58(2):R73-R85. PubMed ID: 27899417 [TBL] [Abstract][Full Text] [Related]
23. Islet β cell mass in diabetes and how it relates to function, birth, and death. Weir GC; Bonner-Weir S Ann N Y Acad Sci; 2013 Apr; 1281(1):92-105. PubMed ID: 23363033 [TBL] [Abstract][Full Text] [Related]
24. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction. Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246 [TBL] [Abstract][Full Text] [Related]
26. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832 [TBL] [Abstract][Full Text] [Related]
27. Islet mass and function in diabetes and transplantation. Weir GC; Bonner-Weir S; Leahy JL Diabetes; 1990 Apr; 39(4):401-5. PubMed ID: 2108068 [TBL] [Abstract][Full Text] [Related]
28. Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates. Bogdani M; Speake C; Dufort MJ; Johnson PY; Larmore MJ; Day AJ; Wight TN; Lernmark Å; Greenbaum CJ Diabetologia; 2020 Mar; 63(3):549-560. PubMed ID: 31907557 [TBL] [Abstract][Full Text] [Related]
29. Interrogating islets in health and disease with single-cell technologies. Carrano AC; Mulas F; Zeng C; Sander M Mol Metab; 2017 Sep; 6(9):991-1001. PubMed ID: 28951823 [TBL] [Abstract][Full Text] [Related]
30. A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation. Chang TT; Lin LY; Chen JW Front Immunol; 2021; 12():650626. PubMed ID: 33968046 [TBL] [Abstract][Full Text] [Related]
31. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans. Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901 [TBL] [Abstract][Full Text] [Related]
32. Diabetes-induced Proteome Changes Throughout Development. Johar D; Ahmed SM; El Hayek S; Al-Dewik N; Bahbah EI; Omar NH; Mustafa M; Salman DO; Fahmey A; Mottawea M; Azouz RAM; Bernstein L Endocr Metab Immune Disord Drug Targets; 2019; 19(6):732-743. PubMed ID: 31038056 [TBL] [Abstract][Full Text] [Related]
33. Intact pancreatic islets and dispersed beta-cells both generate intracellular calcium oscillations but differ in their responsiveness to glucose. Scarl RT; Corbin KL; Vann NW; Smith HM; Satin LS; Sherman A; Nunemaker CS Cell Calcium; 2019 Nov; 83():102081. PubMed ID: 31563790 [TBL] [Abstract][Full Text] [Related]
34. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion. Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624 [TBL] [Abstract][Full Text] [Related]
35. Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetes. Alagpulinsa DA; Cao JJL; Sobell D; Poznansky MC Pharmacol Ther; 2019 Jan; 193():63-74. PubMed ID: 30149101 [TBL] [Abstract][Full Text] [Related]
36. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. van de Bunt M; Gaulton KJ; Parts L; Moran I; Johnson PR; Lindgren CM; Ferrer J; Gloyn AL; McCarthy MI PLoS One; 2013; 8(1):e55272. PubMed ID: 23372846 [TBL] [Abstract][Full Text] [Related]
37. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes. Lawlor N; Stitzel ML Mol Metab; 2019 Sep; 27S(Suppl):S15-S24. PubMed ID: 31500827 [TBL] [Abstract][Full Text] [Related]
38. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat. Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341 [TBL] [Abstract][Full Text] [Related]
39. Genetic lineage tracing identifies adaptive mechanisms of pancreatic islet β cells in various mouse models of diabetes with distinct age of initiation. Fu Q; Qian Y; Jiang H; He Y; Dai H; Chen Y; Xia Z; Liang Y; Zhou Y; Gao R; Zheng S; Lv H; Sun M; Xu K; Yang T Sci China Life Sci; 2024 Mar; 67(3):504-517. PubMed ID: 37930473 [TBL] [Abstract][Full Text] [Related]
40. Recovery of viable endocrine-specific cells and transcriptomes from human pancreatic islet-engrafted mice. Redick SD; Leehy L; Rittenhouse AR; Blodgett DM; Derr AG; Kucukural A; Garber MG; Shultz LD; Greiner DL; Wang JP; Harlan DM; Bortell R; Jurczyk A FASEB J; 2020 Jan; 34(1):1901-1911. PubMed ID: 31914605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]